Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy

Clinical trial NCT06862869 · RECRUITING

Trial details

NCT number: NCT06862869
Sponsor: Hoffmann-La Roche
Status: RECRUITING
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2025-04-30
Primary completion: 2028-10-30
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.